Cumberland Pharmaceuticals (CPIX) Reports Q3 EPS of $0.04

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.04, versus $0.10 reported last year. Revenue for the quarter came in at $7.9 million, versus $9.73 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Humana (HUM) surges on Q1 beat, reiterated adjusted earnings outlook
• Lennox (LII) Tops Q1 EPS by 30c ; Offers Guidance
• Hasbro (HAS) Tops Q1 EPS by 33c, offers guidance